Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_assertion type Assertion NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_head.
- NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_assertion description "[It has been also hypothesized that its specific ligand, KGF, might contribute to the development of resistance to 5-fluorouracil (5-FU) in epithelial cancers and tamoxifen in estrogen-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_provenance.
- NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_assertion evidence source_evidence_literature NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_provenance.
- NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_assertion SIO_000772 18575591 NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_provenance.
- NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_assertion wasDerivedFrom befree-20140225 NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_provenance.
- NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_assertion wasGeneratedBy ECO_0000203 NP845347.RANIDoI4vRco5WDeo05CBN89hMN6xhX7BNceF3twqp6-w130_provenance.